AMRX Long Put Strategy

AMRX (Amneal Pharmaceuticals, Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products with focus on central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers Emverm, a chewable tablet for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; Rytary to treat Parkinson's disease; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs.

AMRX (Amneal Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $3.95B, a trailing P/E of 33.31, a beta of 1.32 versus the broader market, a 52-week range of 7.02-15.42, average daily share volume of 1.9M, a public-listing history dating back to 2018, approximately 8K full-time employees. These structural characteristics shape how AMRX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.32 indicates AMRX has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a long put on AMRX?

A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.

Current AMRX snapshot

As of May 15, 2026, spot at $11.95, ATM IV 51.20%, IV rank 18.14%, expected move 14.68%. The long put on AMRX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long put structure on AMRX specifically: AMRX IV at 51.20% is on the cheap side of its 1-year range, which favors premium-buying structures like a AMRX long put, with a market-implied 1-standard-deviation move of approximately 14.68% (roughly $1.75 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated AMRX expiries trade a higher absolute premium for lower per-day decay. Position sizing on AMRX should anchor to the underlying notional of $11.95 per share and to the trader's directional view on AMRX stock.

AMRX long put setup

The AMRX long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With AMRX near $11.95, the first option leg uses a $11.95 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed AMRX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 AMRX shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Put$11.95N/A

AMRX long put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.

AMRX long put payoff curve

Modeled P&L at expiration across a range of underlying prices for the long put on AMRX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long put on AMRX

Long puts on AMRX hedge an existing long AMRX stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying AMRX exposure being hedged.

AMRX thesis for this long put

The market-implied 1-standard-deviation range for AMRX extends from approximately $10.20 on the downside to $13.70 on the upside. A AMRX long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long AMRX position with one put per 100 shares held. Current AMRX IV rank near 18.14% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on AMRX at 51.20%. As a Healthcare name, AMRX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to AMRX-specific events.

AMRX long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. AMRX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move AMRX alongside the broader basket even when AMRX-specific fundamentals are unchanged. Long-premium structures like a long put on AMRX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current AMRX chain quotes before placing a trade.

Frequently asked questions

What is a long put on AMRX?
A long put on AMRX is the long put strategy applied to AMRX (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With AMRX stock trading near $11.95, the strikes shown on this page are snapped to the nearest listed AMRX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are AMRX long put max profit and max loss calculated?
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the AMRX long put priced from the end-of-day chain at a 30-day expiry (ATM IV 51.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a AMRX long put?
The breakeven for the AMRX long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current AMRX market-implied 1-standard-deviation expected move is approximately 14.68%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long put on AMRX?
Long puts on AMRX hedge an existing long AMRX stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying AMRX exposure being hedged.
How does current AMRX implied volatility affect this long put?
AMRX ATM IV is at 51.20% with IV rank near 18.14%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related AMRX analysis